Quote from CBSA and President & CEO John Collar: The biotech industry does have one inherent advantage in tough times – some of the world’s most innovatory leaders. "Bioscience companies are renowned for excellent management teams," says John Collar, executive director of the Colorado BioScience Association (cobioscience.com). "They, of course, will keep a tight eye on the fundamentals of cost management and implementing innovative lean operational measures, while narrowly focusing on developing products and services with significant market potentials. Firms that bring innovative, lower cost, and more effective products and services to market will not only survive these times, but will be the powerhouses of the industry going forward."Tuesday, March 24, 2009
February 2009 Med Ad News Placement
Quote from CBSA and President & CEO John Collar: The biotech industry does have one inherent advantage in tough times – some of the world’s most innovatory leaders. "Bioscience companies are renowned for excellent management teams," says John Collar, executive director of the Colorado BioScience Association (cobioscience.com). "They, of course, will keep a tight eye on the fundamentals of cost management and implementing innovative lean operational measures, while narrowly focusing on developing products and services with significant market potentials. Firms that bring innovative, lower cost, and more effective products and services to market will not only survive these times, but will be the powerhouses of the industry going forward."
Subscribe to:
Post Comments (Atom)
.jpg){kind=logo}
No comments:
Post a Comment